DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Antonia SJ, Villegas A, Daniel D. et al.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
New Engl J Med 2017;
377: 1919-1929
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.